Ignite Creation Date:
2025-12-18 @ 9:51 AM
Ignite Modification Date:
2025-12-23 @ 9:56 PM
Study NCT ID:
NCT02703714
Status:
None
Last Update Posted:
2022-01-25 00:00:00
First Post:
2016-03-04 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pembrolizumab and GM-CSF in Biliary Cancer
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-04 00:00:00
First Submit QC Date:
None
Study First Post Date:
2016-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-12-13 00:00:00
Results First Submit QC Date:
None
Results First Post Date:
2022-01-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-21 00:00:00
Last Update Post Date:
2022-01-25 00:00:00
Last Update Post Date Type:
ACTUAL